The Superbug Nightmare We Always Feared Is Upon Us

A new discovery “heralds the emergence of truly pan-drug resistant bacteria,” researchers say.

<a href=""></a>/Shutterstock

Let our journalists help you make sense of the noise: Subscribe to the Mother Jones Daily newsletter and get a recap of news that matters.

Late last year, a team of of Chinese and UK researchers shocked the global public health world when they identified a strand of E. coli circulating among Chinese pigs that had developed resistance to colistin, a “last resort” antibiotic that’s used only to treat pathogens that can resist other antibiotics. Worse still, they found, the gene that allowed the E. coli to withstand the potent drug can easily jump to other bacterial species—including nasties like salmonella—and is “likely” to go global. The researchers didn’t mince words: “All the key players are now in place to make the post-antibiotic world a reality,” one of them told the BBC.

So, uh-oh: Researchers at the Walter Reed National Military Medical Center in Maryland have just found colistin-resistant E. coli in a person here in the United States. In response to the bad news from China, the Walter Reed crew had just begun in early May to screen all the E. coli samples that came through the facility’s medical-testing lab for the presence of that highly mobile colistin-resistant gene. It didn’t take them long to find a positive test, which they reported Thursday in the journal Antimicrobial Agents and Chemotherapy. The discovery “heralds the emergence of truly pan-drug resistant bacteria,” they wrote.

The discovery “heralds the emergence of truly pan-drug resistant bacteria.”

The sample came from E. coli found in a urine sample from a 49-year-old Pennsylvania woman “with symptoms indicative of” a urinary-tract infection, they reported. There’s no information on how she picked up the bacteria, but she “reported no travel history within the prior five months,” the researchers wrote.

The incident marks the first known US case of colistin-resistant bacteria in a person. The US Department of Agriculture recently reported finding it in a pig intestine. As predicted, the resistant gene, known as mcr-1, has spread rapidly across the globe. Here’s the US Department of Agriculture:

Following the revelation in China, scientists across the globe began searching for other bacteria containing the mcr-1 gene, and the bacteria have since been discovered in Europe and Canada. The mcr-1 gene exists on a plasmid, a small piece of DNA that is not a part of a bacterium’s chromosome. Plasmids are capable of moving from one bacterium to another, spreading antibiotic resistance between bacterial species.

So far, the Pennsylvania patient’s sample is the only one that has turned up positive for mcr-1, the Walter Reed researchers wrote. “However, as testing has only been ongoing for 3 weeks, it remains unclear what true prevalence of mcr-1 is in the population,” they added.

The Washington Post has more here. And make sure to check out my recent deep-dive into the long history of antibiotic use in US meat production and its connection to the unraveling of antibiotics as a tool for fighting human infections.


Headshot of Editor in Chief of Mother Jones, Clara Jeffery

It sure feels that way to me, and here at Mother Jones, we’ve been thinking a lot about what journalism needs to do differently, and how we can have the biggest impact.

We kept coming back to one word: corruption. Democracy and the rule of law being undermined by those with wealth and power for their own gain. So we're launching an ambitious Mother Jones Corruption Project to do deep, time-intensive reporting on systemic corruption, and asking the MoJo community to help crowdfund it.

We aim to hire, build a team, and give them the time and space needed to understand how we got here and how we might get out. We want to dig into the forces and decisions that have allowed massive conflicts of interest, influence peddling, and win-at-all-costs politics to flourish.

It's unlike anything we've done, and we have seed funding to get started, but we're looking to raise $500,000 from readers by July when we'll be making key budgeting decisions—and the more resources we have by then, the deeper we can dig. If our plan sounds good to you, please help kickstart it with a tax-deductible donation today.

Thanks for reading—whether or not you can pitch in today, or ever, I'm glad you're with us.

Signed by Clara Jeffery

Clara Jeffery, Editor-in-Chief

payment methods

We Recommend